|Page|1|Index|
|---|---|---|
|Page|2|Reference and Administrative
Information|
|Pages|3to 5|Trustees' Report|
|Page|6|Independent
Examiner's
Report|
|Page|7|Statement ofFinancial Activities|
|Page|8|Statement ofFinancial Activities - comparatives|
|Page|9|Balance Sheet|
|Page|10to 16|Notes to the Financial Statements|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted|Restricted|||
|---|---|---|---|---|---|
|||funds|funds|||
|||||Total|Total|
||Notes|||2023|2022|
|Income and endowments|from:|||||
|Charitable
Activities|||29,157|29,157|55,725|
|Income from investments|||85|85|7|
|Total|||29,242|29,242|55,732|
|Expenditure
on:||||||
|Charitable
Activities||||||
|GP Tutor
Clinical tutor||285|3,634
15,764|3,634
16,049|9,642
17,076|
|Clinical tutor MRCP|||60|60|120|
|VTS|||1,089|1,089|1,397|
|Surgical Tutor
A8'cE|||10,482
260|10,482
260|11,429
944|
|Histopathology|||560|560|520|
|Council|||60|60|20|
|Total||285|31,909|32,194|41,148|
|Net income/ (expenditure)||(285)|(2,667)|(2,952)|14,584|
|Funds at 1stApril 2022 brought forward||(344)|177,174|176,830|162,246|
|Funds at 31stMarch 2023|carried forward|(629)|174,507|173,878|176,830|
##
||||Unrestricted|Restricted|||
|---|---|---|---|---|---|---|
||||funds|funds|||
||||||Total|Total|
|||Notes|||2022|2021|
|Income and endowments|from:||||||
|Charitable
Activities||3||55,725|55,725|15,850|
|Income &om investments||2||7|7|495|
|Total||||55,732|55,732|16,345|
|Expenditure
on:|||||||
|Charitable
Activities|||||||
|GP Tutor||||9,642|9,642|12,724|
|Clinical tutor|||351|16,725|17,076|2,876|
|Clinical tutor MRCP
VTS||||120
1,397|120
1,397|3,600
100|
|Surgical Tutor
A&E||||11,429
944|11,429
944|1,163
500|
|Histopathology||||520|520||
|Council||||20|20||
|Total|||351|40,797|41,148|20,963|
|Net income/ (expenditure)|||(351)|14,935|14,584|(4,618)|
|Funds at 1stApril 2021 brought||forws|7|162,239|162,246|166,864|
|Funds at 31stMarch 2022|carried fon||(344)|177,174|176,830|162,246|
##
##
|||Note|2023|2022|
|---|---|---|---|---|
|Fixed Assets|||||
|Tangible assets|||1,266|1,551|
|Current Assets|||||
|Debtors||||4,222|
|Cash at bank and|in hand||176,224|174,497|
||||176,224|178,719|
|Creditors: amounts|falling due within one year|10|3,612|3,440|
|Net Assets|||173,878|176,830|
|Funds|||||
|Restricted||11|174,507|177,174|
|Unrestricted|||(629)|(344)|
||||173,878|176,830|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||Clinincal|Clinincal|VTS|Surgical|A&E|Council|Histo-|Total||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||GP|Tutor|Tutor|Tutor||Tutor|||pathology|||
||||||||MRCP
f||f||||2023||
|Sponsorship||||||918|2,259|6,000|500|580|||10,257||
|Fees|||||||||4,200||||4,200||
|Learning
Sets|||||||||||||||
|ATLS||||||14,700|||||||14,700||
|||||||15,618|2,259|6,000|4,700|580|||29,157||
|||||||Clinincal|Clininca!|VTS|Surgical|A&E|Council|Histo-|Total||
||||GP||Tutor|Tutor|Tutor||Tutor|||pathology|||
||||||||MRCP||||||2022||
|Sponsorship
Fees||||||||6,000|3,500
20,300||||9,500
20,300||
|Learning
Sets|||||||||||||||
|ATLS||||||17,825|8,100||||||25,925||
|||||||17,825|8,100|6,000|23,800||||55,725||
|Expenditure|on Charitable|||activities|||||||||||
|||||||Clinincal|Clinincal|VTS|Surgical||Council|Histo-|Total|Total|
||||GP Tutor|||Tutor|Tutor||Tutor|||pathology|||
|||||||f|MRCP||||||2023|2022|
|Depreciation||||||285|||||||285|351|
|Repairs and|renwals|||||||||||||130|
|Catering
Speakers
Room hire
Computer
equipment|||||159
1,865
1,044|5,438
850||568
260|1,987
728||||7,584
3,283
1,044
988|8,208
9,420
1,049|
|ATLS
Courses and
Simulation|staff training|||||5,390
64|||7,186||||5,390
7,186
64|11,502
5,377|
|Bank charges|||||66|90|60|61|81|60|60|60|538|179|
|Stationary||||||24|||||||24|71|
|Promotional|expenses||||||||||||||
|Miscellaneous||||||2,196|||||||2,196|1,385|
||||||3,134|14,337|60|889|9,982|60|60|60|28,582|37,672|
|Share ofgovernance||costs|||500|1,712||200|500|200|-|500|3,612|3,476|
||||||3,634|16,049|60|1,089|10,482|260|60|560|32,194|41,148|
|Analysis
by|fund current||year||||||||||||
|Unrestricted|funds|||||285|||||||285||
|Restricted funds|||||3,634|15,764|60|1,089|10,482|260|60|560|31,909||
||||||3,634|16,049|60|1,089|10482|260|60|560|32,194||
|Analysis
by|fund previous|||year|||||||||||
|Unrestricted|funds|||||351|||||||351||
|Restricted funds|||||9,642|16,725|120|1,397|11,429|944|20|520|40,797||
||||||9,642|17,076|120|1,397|11,429|944|20|520|41,148||
##
##
##
##
##
|||||||Clinincal|Clinincal|VTS|Surgical|A&E|Council|Histo-|Total|Total||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||GP|Tutor|Tutor|Tutor||Tutor|||pathology||||
||||||||MRCP||||||2022|2021||
|Depreciation
Repairs and|reuwals|||||351
130|||||||351
130||431|
|Catering
Speakers
Room hire
Computer
equipment
ATLS
Courses and staff training
Simulation|||||399
8,450
174
70|2,625
82
11,502
35|||4,760
875
5,272|424|||8,208
9,420
1,049
11,502
5,377|32
7,954
350
312
7,623||
|Bank charges|||||23|33|20|21|22|20|20|20|179|||
|Stationary||||||71|||||||71|||
|Promotional|expenses|||||||||||||||
|Miscellaneous|||||26
9,142|1,071
15,900|20|1,197|10,929|444|20|20|1,385
37,672|985
17,687||
|Share ofgovernance||costs|||500|1,176|100|200|500|500|—|500|3,476|3,276||
||||||9,642|17,076|120|1,397|11,429|944|20|520|41,148|20,963||
|Analysis
by|fund previous|||year||||||||||||
|Unrestricted|funds|||||351|||||||351|||
|Restricted funds|||||9,642
9,642|16,725
17,076|120
120|1,397
1,397|11,429
11,429|944
944|20
20|520
520|40,797
41,148|||
|Support Costs||||||||||||Total|Total|||
|||||||||||||2023|2022|||
|Independent|examiners||fee|||||||||3,612|3,476|||
|All support|costs are allocated||||to charitable
activities.|||||||||||
##
##
##
##
|8.|Tangible fixed assets||Fixtures|Computers|Total|
|---|---|---|---|---|---|
||||and fitting|||
||Cost|||||
||At 1stApril 2022||2,509|9,927|12,436|
||Additions|||||
||At 31stMarch 2023||2,509|9,927|12,436|
||Depreciation
and impairment|||||
||At 1stApril 2022||2,001|8,884|10,885|
||Depreciation
charged in the year||76|209|285|
||At 31stMarch 2023||2,077|9,093|11,170|
||Carrying
amount|||||
||At 31stMarch 2023||432|834|1,266|
||At 31stMarch 2022||508|1,043|1,551|
|9.|Debtors|||2023|2022|
||Amounts
falling due within one year:|||||
||Other debtors||||4,222|
|10.|Creditors: amount falling due within|one year||2023|2022|
||Accruals and deferred income|||3,612|3,440|
##
##
##
##
|Movement
in Funds|- current year||||||
|---|---|---|---|---|---|---|
||Balances|Incoming|Investmeni|Transfers|Resources|Balances|
||1.4.2022|resources|income||expended|31.3.2023|
|GP Tutor|12,931||||3,634|9,297|
|Clinical tutor|52,471|15,618|85|-|15,764|52,410|
|Barron Fund|27„624|||||27,624|
|General Fund|115|||||115|
|Clinical tutor MRCP|8,374|2,259|||60|10,573|
|VTS|21,534|6,000|||1,089|26,445|
|Surgical Tutor|47,379|4,700|||10,482|41,597|
|AXE|4,916||||260|4,656|
|Council|(20)||||60|(80)|
|Histopathology|1,850||||560|1,290|
||177,174|28,577|85||31,909|173,927|
|Movement
in Funds - previous year|||||||
||Balances|Incoming|Investment|Transfers|Resources|Balances|
||1.4.2021|resources|income||expended|31.3.2022|
|GP Tutor|22,573||||9,642|12,931|
|Clinical tutor|51,364|17,825|7|-|16725|52,471|
|Barron Fund|27,624|||||27,624|
|General Fund|115|||||115|
|Clinical tutor MRCP|394|8,100|||120|8,374|
|VTS|16,931|6,000|||1,397|21,534|
|Surgical Tutor
ARE|35,008
5,860|23,800|||11,429
944|47,379
4,916|
|Council|||||20|(20)|
|Histopathology|2,370||||520|1,850|
||162,239|55,725|||40,797|177,174|